Clinical Trials Logo
  1. Home
  2. Venous Thromboembolism
  3. NCT02156401

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE — VTEval  

Venous Thromboembolism (VTE) Clinical Trial

Official title:
VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism

Clinical Trial Summary

Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries with several aspects in need to be addressed. VTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE). The standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02156401
Study type Observational
Source Johannes Gutenberg University Mainz
Contact Philipp S Wild, MD, MSc
Phone 0049 6131 17 7163
Email philipp.wild@unimedizin-mainz.de
Status Recruiting
Phase
Start date April 2013
Completion date July 2023
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03265054 - Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis N/A
Completed NCT04141228 - A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US
Completed NCT01119274 - EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon Phase 4
Completed NCT03965741 - Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners
Completed NCT02798471 - Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) Phase 3
Completed NCT01583218 - Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) Phase 3
Completed NCT03521908 - A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
Recruiting NCT03802929 - Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism
Completed NCT02073682 - Cancer Venous Thromboembolism (VTE) Phase 3
Completed NCT03977870 - Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis
Recruiting NCT06057844 - Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET) N/A
Active, not recruiting NCT04243122 - Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients Phase 2